Deutsche Bank Downgrades Team Health (TMH) to Hold
- Q2 GDP 4% vs 3% Expected
- Pre-Open Stock Movers 7/30: (GFIG) (TWTR) (NQ) Higher; (NTRI) (BWLD) (DWA) Lower (more...)
- U.S. Private Sector Adds Fewer Jobs in July
- Twitter, Inc. (TWTR) Posts Q2 EPS of 2c/Share, Beats Views; Guides FY14 Revs Above Expectations
- Hess Corp. (HES) Plans Formation, IPO of MLP
Deutsche Bank downgraded Team Health (NYSE: TMH) from Buy to Hold with a price target of $53.00 (unchanged).
Analyst Darren Lehrich said, "We are downgrading TMH shares to Hold from Buy, although we maintain our favorable view on the company's L-T outlook and positioning in the physician outsourcing market. At current valuation levels (~11.5x DB's Street-high 2015E adj. EBITDA), we consider the risk-reward to be more in balance in the context of TMH's moderating growth and well-understood ACA upside risks. We acknowledge there could still be some upside risks associated with ACA, but we remind investors that TMH's EV/EBITDA multiple has re-rated 300+ bps since we aggressively emphasized ACA upside risks in mid-2012. A Hold rating now better reflects our views on TMH shares; $53 PT / ests unchanged."
Shares of Team Health closed at $51.96 yesterday.
You May Also Be Interested In
- UPDATE: JPMorgan Downgrades Alaska Air (ALK) to Neutral
- UPDATE: JPMorgan Upgrades United Continental (UAL) to Overweight
- Twitter (TWTR) PT Raised to $52 at Macquarie
Create E-mail Alert Related CategoriesAnalyst Comments, Analyst EPS View, Downgrades
Related EntitiesDeutsche Bank
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!